USE OF UBE3A UBIQUITINATION PP2A ACTIVATING FACTOR PTPA IN TREATING ANGELMAN SYNDROME AND… Application WO-2020168850-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020